Molecular dissection of pain mediators

Pain Reviews

Volumn 7, Issue 1, 2000, Pages 37-64

  Luo, Z David ^a,b  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE CONTROL; GENE EXPRESSION; HUMAN; MOLECULAR BIOLOGY; NERVE CONDUCTION; NOCICEPTION; NONHUMAN; PAIN; RAT; REVIEW;

EID: 0033929415     PISSN: 09681302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (287)

1. Woolf CJ. Pain. Curr Opin CPNS Invest Drugs 1999; 1: 2-3.
2. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci U S A 1999; 96: 7680-86.
3. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A 1999; 96: 7723-30.
4. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-64.
5. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-71.
6. Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 1993; 21: 3269-75.
7. Liang P, Bauer D, Averboukh L et al. Analysis of altered gene expression by differential display. Methods Enzymol 1995; 254: 304-21.
8. Wan JS, Sharp SJ, Poirier G et al. Cloning differentially expressed mRNAs. Nat Biotechnol 1996; 14: 1685-91.
9. Watson JB, Margulies JE. Differential cDNA screening strategies to identify novel stage-specific proteins in the developing mammalian brain. Dev Neurosci 1993; 15: 77-86.
10. Liang P, Pardee AB. Recent advances in differential display. Curr Opin Immunol 1995; 7: 274-80.
11. Poirier GM, Pyati J, Wan JS, Erlander MG. Screening differentially expressed cDNA clones obtained by differential display using amplified RNA. Nucleic Acids Res 1997; 25: 913-14.
12. Poirier GM, Erlander MG. Postdifferential display: parallel processing of candidates using small amounts of RNA. Methods 1998; 16: 444-52.
13. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-70.
14. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol 1998; 16: 301-306.
15. Schena M. Genome analysis with gene expression microarrays. Bioessays 1996; 18: 427-31.
16. Green ED, Waterston RH. The human genome project. Prospects and implications for clinical medicine. Jama 1991; 266: 1966-75.
17. Morton NE. Parameters of the human genome. Proc Natl Acad Sci USA 1991; 88: 7474-76.
18. Bellanné-Chantelot C, Lacroix B, Ougen P et al. Mapping the whole human genome by fingerprinting yeast artificial chromosomes. Cell 1992; 70: 1059-68.
19. Cox DR, Green ED, Lander ES, Cohen D, Myers RM. Assessing mapping progress in the Human Genome Project. Science 1994; 265: 2031-32.
20. Luo L, Salunga RC, Guo H et al. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 1999; 5: 117-22.
21. Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture microdissection. Science 1996; 274: 998-1001.
22. Carrión AM, Mellström B, Luckman SM, Naranjo JR. Stimulus-specific hierarchy of enhancer elements within the rat prodynorphin promoter. J Neurochem 1998; 70: 914-21.
23. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-824.
24. Zhou XF, Chie ET, Deng YS et al. Injured primary sensory neurons switch phenotype for brain-derived neurotrophic factor in the rat. Neuroscience 1999; 92: 841-53.
25. Mannion RJ, Costigan M, Decosterd I et al. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA 1999; 96: 9385-90.
26. Cho HJ, Kim JK, Zhou XF, Rush RA. Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res 1997; 764: 269-72.
27. Cho HJ, Kim SY, Park MJ, Kim DS, Kim JK, Chu MY. Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation. Brain Res 1997; 749: 358-62.
28. Michael GJ, Averill S, Nitkunan A et al. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 1997; 17: 8476-90.
29. Xu XJ, Puke MJ, Verge VM, Wiesenfeld-Hallin Z, Hughes J, Hökfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Lett 1993; 152: 129-32.
30. Antunes Bras JM, Laporte AM, Benoliel JJ et al. Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cord. J Neurochem 1999; 72: 858-67.
31. Hammond DL, Presley R, Gogas KR, Basbaum AI. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J Comp Neurol 1992; 315: 244-53.
32. Hylden JL, Noguchi K, Ruda MA. Neonatal capsaicin treatment attenuates spinal Fos activation and dynorphin gene expression following peripheral tissue inflammation and hyperalgesia. J Neurosci 1992; 12: 1716-25.
33. Huang W, Simpson RK. Antisense of c-fos gene attenuates Fos expression in the spinal cord induced by unilateral constriction of the sciatic nerve in the rat. Neurosci Lett 1999; 263: 61-64.
34. Menétrey D, Gannon A, Levine JD, Basbaum AI. Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol 1989; 285: 177-95.
35. Chi SI, Levine JD, Basbaum AI. Peripheral and central contributions to the persistent expression of spinal cord fos-like immunoreactivity produced by sciatic nerve transection in the rat. Brain Res 1993; 617: 225-37.
36. Luo L, Ji RR, Zhang Q, Iadarola MJ, Hökfelt T, Wiesenfeld-Hallin Z. Effect of administration of high dose intrathecal clonidine or morphine prior to sciatic nerve section on c-fos expression in rat lumbar spinal cord. Neuroscience 1995; 68: 1219-27.
37. Ji RR, Zhang X, Wiesenfeld-Hallin Z, Hökfelt T. Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J Neurosci 1994; 14: 6423-34.
38. Fukuoka T, Tokunaga A, Kondo E, Miki K, Tachibana T, Noguchi K. Change in mRNAs for neuropeptides and the GABA(A) receptor in dorsal root ganglion neurons in a rat experimental neuropathic pain model. Pain 1998; 78: 13-26.
39. Hökfelt T, Zhang X, Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994; 17: 22-30.
40. Weihe E, Nohr D, Schäfer MK et al. Calcitonin gene related peptide gene expression in collagen-induced arthritis. Can J Physiol Pharmacol 1995; 73: 1015-19.
41. Nohr D, Schäfer MK, Persson S et al. Calcitonin gene-related peptide gene expression in collagen-induced arthritis is differentially regulated in primary afferents and motoneurons: influence of glucocorticoids. Neuroscience 1999; 93: 759-73.
42. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992; 49: 693-98.
43. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62: 327-31.
44. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995; 115: 1265-75.
45. Ebersberger A, Grubb BD, Willingale HL, Gardiner NJ, Nebe J, Schaible HG. The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an up-regulation of cyclo-oxygenase-2 in the spinal cord. Neuroscience 1999; 93: 775-81.
46. MacArthur L, Ren K, Pfaffenroth E, Franklin E, Ruda MA. Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia. Neuroscience 1999; 88: 499-506.
47. Ji RR, Zhang Q, Zhang X et al. Prominent expression of bFGF in dorsal root ganglia after axotomy. Eur J Neurosci 1995; 7: 2458-68.
48. Zhang X, Dagerlind A, Bao L, Ji RR, Lundberg JM, Hökfelt T. Increased expression of galanin in the rat superiour cervical ganglion after pre- and postganglionic nerve lesions. Exp Neurol 1994; 127: 9-22.
49. Ji RR, Zhang Q, Bedecs K et al. Galanin antisense oligonucleotides reduce galanin levels in dorsal root ganglia and induce autotomy in rats after axotomy. Proc Natl Acad Sci U S A 1994; 91: 12540-43.
50. Ji RR, Zhang X, Zhang Q et al. Central and peripheral expression of galanin in response to inflammation. Neuroscience 1995; 68: 563-76.
51. Ji RR, Zhang Q, Pettersson RF, Hökfelt T. aFGF, bFGF and NGF differentially regulate neuropeptide expression in dorsal root ganglia after axotomy and induce autotomy. Regul Pept 1996; 66: 179-89.
52. Zhang X, Xu ZO, Shi TJ, et al. Regulation of expression of galanin and galanin receptors in dorsal root ganglia and spinal cord after axotomy and inflammation. Ann N Y Acad Sci 1998; 863: 402-13.
53. Ma W, Bisby MA. Increase of galanin mRNA in lumbar dorsal root ganglion neurons of adult rats after partial sciatic nerve ligation. Neurosci Lett 1999; 262: 195-98.
54. Shi TJ, Cui JG, Meyerson BA, Linderoth B, Hökfelt T. Regulation of galanin and neuropeptide Y in dorsal root ganglia and dorsal horn in rat mononeuropathic models: possible relation to tactile hypersensitivity. Neuroscience 1999; 93: 741-57.
55. Kerekes N, Landry M, Hökfelt T. Leukemia inhibitory factor regulates galanin/galanin message-associated peptide expression in cultured mouse dorsal root ganglia; with a note on in situ hybridization methodology. Neuroscience 1999; 89: 1123-34.
56. Boxall SJ, Berthele A, Laurie DJ et al. Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation. Neuroscience 1998; 82: 591-602.
57. Arruda JL, Colburn RW, Rickman AJ, Rutkowski MD, DeLeo JA. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. Brain Res Mol Brain Res 1998; 62: 228-35.
58. Gillardon F, Wiesner RJ, Zimmermann M. Expression of the junD proto-oncogene in the rat spinal cord and skin following noxious cutaneous ultraviolet irradiation. Neurosci Lett 1992; 136: 87-90.
59. Gies EK, Peters DM, Gelb CR, Knag KM, Peterfreund RA. Regulation of mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells. Anesthesiology 1997; 87: 1127-38.
60. Zhang X, Bao L, Shi TJ, Ju G, Eide R, Hökfelt T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998; 82: 223-40.
61. Goff JR, Burkey AR, Goff DJ, Jasmin L. Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience 1998; 82: 559-74.
62. Ji RR, Zhang Q, Law PY, Low HH, Eide R, Hökfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 1995; 15: 8156-66.
63. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurones and down-regulated after axotomy. Proc Natl Acad Sci U S A 1998; 95: 8963-68.
64. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc Natl Acad Sci U S A 1999; 96: 7635-39.
65. McCarson KE, Krause JE. The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration. Neuroscience 1995; 64: 729-39.
66. McCarson KE, Krause JE. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J Neurosci 1994; 14: 712-20.
67. Krause JE, DiMaggio DA, McCarson KE. Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation. Can J Physiol Pharmacol 1995; 73: 854-59.
68. Leslie TA, Emson PC, Dowd PM, Woolf CJ. Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation. Neuroscience 1995; 67: 753-61.
69. Zhang X, Ji RR, Nilsson S et al. Neuropeptide Y and galanin binding sites in rat and monkey lumbar dorsal root ganglia and spinal cord and effect of peripheral axotomy. Eur J Neurosci 1995; 7: 367-80.
70. Vilim FS, Aarnisalo AA, Nieminen ML et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 1999; 55: 804-11.
71. Renno WM. Prolonged noxious stimulation increases periaqueductal gray NMDA mRNA expression: a hybridization study using two different rat models for nociception. Ir J Med Sci 1998; 167: 181-92.
72. Luo Z, Chaplan S, Scott B, Cizkova D, Calcutt N, Yaksh T. Neuronal nitric oxide synthase mRNA up-regulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development. J Neurosci 1999; 19: 9201-208.
73. Verge VM, Xu Z, Xu XJ, Wiesenfeld-Hallin Z, Hökfelt T. Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc Natl Acad Sci USA 1992; 89: 11617-21.
74. Steel JH, Terenghi G, Chung JM, Na HS, Carlton SM, Polak JM. Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci Lett 1994; 169: 81-84.
75. Martin WJ, Liu H, Wang H, Malmberg AB, Basbaum AI. Inflammation-induced up-regulation of protein kinase Cgamma immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing. Neuroscience 1999; 88: 1267-74.
76. Draisci G, Kajander KC, Dubner R, Bennett GJ, Iadarola MJ. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res 1991; 560: 186-92.
77. Nakamura F. [Expression of preprodynorphin mRNA in the spinal cord after inflammatory abdominal stimulation in rats.] Hokkaido Igaku Zasshi 1994; 69: 95-103.
78. Hermanson O, Blomqvist A. Differential expression of the AP-1/CRE-binding proteins FOS and CREB in preproenkephalin mRNA-expressing neurones of the rat parabrachial nucleus after nociceptive stimulation. Brain Res Mol Brain Res 1997; 51: 188-96.
79. Nishimori T, Buzzi MG, Chudler EH, Poletti CE, Moskowitz MA, Uhl GR. Preproenkephalin upregulation in nucleus caudalis: high and low intensity afferent stimulation differentially modulate early and late responses. J Comp Neurol 1990; 302: 1002-18.
80. Andoh T, Itoh M, Kuraishi Y. Nocicepton gene expression in rat dorsal root ganglia induced by peripheral inflammation. NeuroReport 1997; 8: 2793-96.
81. Noguchi K, Ruda MA. Gene regulation in an ascending nociceptive pathway: inflammation-induced increase in preprotachykinin mRNA in rat lamina I spinal projection neurons. J Neurosci 1992; 12: 2563-72.
82. Waxman SG, Kocsis JD, Black JA. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurones, and is reexpressed following axotomy. J Neurophysiol 1994; 72: 466-70.
83. Tate S, Benn S, Hick C et al. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nat Neurosci 1998; 1: 653-55.
84. Okuse K, Chaplan SR, McMahon SB et al. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain. Mol Cell Neurosci 1997; 10: 196-207.
85. Dib-Hajj S, Black JA, Felts P, Waxman SG. Down-regulation of transcripts for Na channel alpha-SNS in spinal sensory neurons following axotomy. Proc Natl Acad Sci U S A 1996; 93: 14950-54.
86. Novakovic SD, Tzoumaka E, McGivern JG et al. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 1998; 18: 2174-87.
87. Porreca F, Lai J, Bian D et al. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci U S A 1999; 96: 7640-44.
88. Gould HJ, England JD, Liu ZP, Levinson SR. Rapid sodium channel augmentation in response to inflammation induced by complete Freund's adjuvant. Brain Res 1998; 802: 69-74.
89. + channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model. NeuroReport 1998; 9: 967-72.
90. Akopian AN, Okuse K, Souslova V, England S, Ogata N, Wood JN. Trans-splicing of a voltage-gated sodium channel is regulated by nerve growth factor. FEBS Lett 1999; 445: 177-82.
91. Blackburn-Munro G, Fleetwood-Walker SM. The sodium channel auxiliary subunits betal and beta2 are differentially expressed in the spinal cord of neuropathic rats. Neuroscience 1999; 90: 153-64.
92. Zhang Q, Ji RR, Lindsay R, Hökfelt T. Effect of growth factors on substance P mRNA expression in axotomized dorsal root ganglia. NeuroReport 1995; 6: 1309-1312.
93. Kenney AM, Kocsis JD. Timing of c-jun protein induction in lumbar dorsal root ganglia after sciatic nerve transection varies with lesion distance. Brain Res 1997; 751: 90-95.
94. Kenney AM, Kocsis JD. Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia in vivo. J Neurosci 1998; 18: 1318-28.
95. Herdegen T, Zimmermann M. Expression of c-Jun and JunD transcription factors represent specific changes in neuronal gene expression following axotomy. Prog Brain Res 1994; 103: 153-71.
96. Ambron RT, Walters ET. Priming events and retrograde injury signalls. A new perspective on the cellular and molecular biology of nerve regeneration. Mol Neurobiol 1996; 13: 61-79.
97. Herdegen T, Rüdiger S, Mayer B, Bravo R, Zimmermann M. Expression of nitric oxide synthase and colocalisation with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw. Brain Res Mol Brain Res 1994; 22: 245-58.
98. Schwarzschild MA, Cole RL, Hyman SE. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J Neurosci 1997; 17: 3455-66.
99. Xia Z, Dudek H, Miranti CK, Greenberg ME. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J Neurosci 1996; 16: 5425-36.
100. Heath MJ, Womack MD, MacDermott AB. Substance P elevates intracellular calcium in both neurons and glial cells from the dorsal horn of the spinal cord. J Neurophysiol 1994; 72: 1192-98.
101. 2+-regulated transcriptional repressor. Nature 1999; 398: 80-84.
102. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism [published erratum appears in Neuron 1998; 20: 1297]. Neuron 1998; 20: 709-26.
103. Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998; 20: 727-40.
104. Lorimer DD, Matkowskj K, Benya RV. Cloning, chromosomal location, and transcriptional regulation of the human galanin-1 receptor gene (GALN1R). Biochem Biophys Res Commun 1997; 241: 558-64.
105. Wang Y, Newton DC, Marsden PA. Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 1999; 13: 21-43.
106. Carrión AM, Mellström B, Naranjo JR. Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol 1998; 18: 6921-29.
107. Messersmith DJ, Kim DJ, Iadarola MJ. Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Brain Res Mol Brain Res 1998; 53: 260-69.
108. Messersmith DJ, Gu J, Dubner R, Douglass J, Iadarola MJ. Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol Cell Neurosci 1994; 5: 238-45.
109. Naranjo JR, Mellström B, Achaval M, Sassone-Corsi P. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 1991; 6: 607-17.
110. Jimenez-Garcia LF, Spector DL. In vivo evidence that transcription and splicing are co-ordinated by a recruiting mechanism. Cell 1993; 73: 47-59.
111. Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995; 59: 423-50.
112. Leedman PJ, Stein AR, Chin WW. Regulated specific protein binding to a conserved region of the 3′-untranslated region of thyrotropin beta-subunit mRNA. Mol Endocrinol 1995; 9: 375-87.
113. Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genet 1996; 12: 171-75.
114. Day DA, Tuite MF. Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 1998; 157: 361-71.
115. Rio DC. Splicing of pre-mRNA: mechanism, regulation and role in development. Curr Opin Genet Dev 1993; 3: 574-84.
116. Fu XD. The superfamily of arginine/serine-rich splicing factors. RNA 1995; 1: 663-80.
117. Robberson BL, Cote GJ, Berget SM. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 1990; 10: 84-94.
118. Nair AP, Hahn S, Banholzer R, Hirsch HH, Moroni C. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 1994; 369: 239-42.
119. Tang B, Wang M, Wise BC. Nerve growth factor mRNA stability is controlled by a cis-acting instability determinant in the 3′-untranslated region. Brain Res Mol Brain Res 1997; 46: 118-26.
120. Helfman DM, Roscigno RF, Mulligan GJ, Finn LA, Weber KS. Identification of two distinct intron elements involved in alternative splicing of beta-tropomyosin pre-mRNA. Genes Dev 1990; 4: 98-110.
121. Guo W, Mulligan GJ, Wormsley S, Helfman DM. Alternative splicing of beta-tropomyosin pre-mRNA: cis-acting elements and cellular factors that block the use of a skeletal muscle exon in nonmuscle cells. Genes Dev 1991; 5: 2096-107.
122. Luo ZD, Camp S, Mutero A, Taylor P. Splicing of 5′ introns dictates alternative splice selection of acetylcholinesterase pre-mRNA and specific expression during myogenesis. J Biol Chem 1998; 273: 28486-95.
123. Wendel B, Hoehe MR. The human mu opioid receptor gene: 5′ regulatory and intronic sequences. J Mol Med 1998; 76: 525-32.
124. Kolesnikov YA, Pan YX, Babey AM, Jain S, Wilson R, Pasternak GW. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci U S A 1997; 94: 8220-25.
125. Chen CC, England S, Akopian AN, Wood JN. A sensory neuron-specific, proton-gated ion channel. Proc Natl Acad Sci USA 1998; 95: 10240-45.
126. Lingueglia E, de Weille JR, Bassilana F et al. A modulatory subunit of acid sensing ion channels in brain and dorsal root ganglion cells. J Biol Chem 1997; 272: 29778-83.
127. Kim HL, Kim H, Lee P, King RG, Chin H. Rat brain expresses an alternatively spliced form of the dihydropyridine-sensitive L-type calcium channel alpha 2 subunit [published erratum appears in Proc Natl Acad Sci U S A 1992; 89: 5699]. Proc Natl Acad Sci U S A 1992; 89: 3251-55.
128. Brust PF, Simerson S, McCue AF et al. Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology 1993; 32: 1089-102.
129. Angelotti T, Hofmann F. Tissue-specific expression of splice variants of the mouse voltage-gated calcium channel alpha2/delta subunit. FEBS Lett 1996; 397: 331-37.
130. Gavériaux-Ruff C, Peluso J, Befort K, Simonin F, Zilliox C, Kieffer BL. Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta- and kappa-opioid receptors. Brain Res Mol Brain Res 1997; 48: 298-304.
131. Fritschy JM, Meskenaite V, Weinmann O, Honer M, Benke D, Mohler H. GABAB-receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization. Eur J Neurosci 1999; 11: 761-68.
132. Oh Y, Waxman SG. Novel splice variants of the voltage-sensitive sodium channel alpha subunit. NeuroReport 1998; 9: 1267-72.
133. Durand GM, Gregor P, Zheng X, Bennett MV, Uhl GR, Zukin RS. Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci U S A 1992; 89: 9359-63.
134. Brenman JE, Xia H, Chao DS, Black SM, Bredt DS. Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci 1997; 19: 224-31.
135. Hentze MW. Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. Biochim Biophys Acta 1991; 1090: 281-92.
136. Peltz SW, Brewer G, Bernstein P, Hart PA, Ross J. Regulation of mRNA turnover in eukaryotic cells. Crit Rev Eukaryot Gene Expr 1991; 1: 99-126.
137. Peltz SW, Jacobson A. mRNA stability: in trans-it. Curr Opin Cell Biol 1992; 4: 979-83.
138. Ren K, Thomas DA, Dubner R. Nerve growth factor alleviates a painful peripheral neuropathy in rats. Brain Res 1995; 699: 286-92.
139. Ramer MS, Kawaja MD, Henderson JT, Roder JC, Bisby MA. Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci Lett 1998; 251: 53-56.
140. McMahon SB, Bennett DL, Priestley JV, Shelton DL. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995; 1: 774-80.
141. Woolf CJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996; 351: 441-48.
142. Ma QP, Woolf CJ. The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent. NeuroReport 1997; 8: 807-10.
143. Mendell LM, Albers KM, Davis BM. Neurotrophins, nociceptors, and pain. Microsc Res Tech 1999; 45: 252-61.
144. Nicholas RS, Winter J, Wren P, Bergmann R, Woolf CJ. Peripheral inflammation increases the capsaicin sensitivity of dorsal root ganglion neurons in a nerve growth factor-dependent manner. Neuroscience 1999; 91: 1425-33.
145. Ensor E, Kendall G, Allchorne A, Woolf CJ, Latchman DS. Induction of the Oct-2 transcription factor in primary sensory neurons during inflammation is nerve growth factor-dependent. Neurosci Lett 1996; 204: 29-32.
146. + channel III and SNS gene expression in spinal sensory neurons. NeuroReport 1997; 8: 2331-35.
147. Dib-Hajj SD, Black JA, Cummins TR, Kenney AM, Kocsis JD, Waxman SG. Rescue of alpha-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo. J Neurophysiol 1998; 79: 2668-76.
148. Jansen M, de Moor CH, Sussenbach JS, van den Brande JL. Translational control of gene expression. Pediatr Res 1995; 37: 681-86.
149. Gray NK, Wickens M. Control of translation initiation in animals. Annu Rev Cell Dev Biol 1998; 14: 399-458.
150. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-88.
151. Reichling DB, MacDermott AB. NMDA receptor-mediated calcium entry in the absence of AMPA receptor activation in rat dorsal horn neurons. Neurosci Lett 1996; 204: 17-20.
152. Dayanithi G, Rage F, Richard P, Tapia-Arancibia L. Characterization of spontaneous and N-methyl-D-aspartate-induced calcium rise in rat cultured hypothalamic neurons. Neuroendocrinology 1995; 61: 243-55.
153. Kelso SR, Nelson TE, Leonard JP. Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol (Lond) 1992; 449: 705-18.
154. Xiong ZG, Raouf R, Lu WY et al. Regulation of N-methyl-D-aspartate receptor function by constitutively active protein kinase C. Mol Pharmacol 1998; 54: 1055-63.
155. Lu WY, Xiong ZG, Lei S et al. G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 1999; 2: 331-38.
156. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992; 356: 521-23.
157. 2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel. J Physiol (Lond) 1998; 506: 33-52.
158. Dubner R, Bennett GJ. Spinal and trigeminal mechanisms of nociception. Annu Rev Neurosci 1983; 6: 381-418.
159. Chen L, Huang LY. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 1991; 7: 319-26.
160. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995; 270: 28495-98.
161. Raymond LA, Blackstone CD, Huganir RL. Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity. Trends Neurosci 1993; 16: 147-53.
162. Suen PC, Wu K, Xu JL, Lin SY, Levine ES, Black IB. NMDA receptor subunits in the postsynaptic density of rat brain: expression and phosphorylation by endogenous protein kinases. Brain Res Mol Brain Res 1998; 59: 215-28.
163. Lieberman DN, Mody I. Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Nature 1994; 369: 235-39.
164. Tong G, Shepherd D, Jahr CE. Synaptic desensitization of NMDA receptors by calcineurin. Science 1995; 267: 1510-12.
165. Lin SY, Wu K, Levine ES, Mount HT, Suen PC, Black IB. BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res Mol Brain Res 1998; 55: 20-27.
166. Yu XM, Askalan R, Keil GJ, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 1997; 275: 674-78.
167. Lau LF, Huganir RL. Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J Biol Chem 1995; 270: 20036-41.
168. Wang YT, Salter MW. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 1994; 369: 233-35.
169. Ji R-R, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999; 2: 1114-19.
170. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
171. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 1998; 21: 869-83.
172. Impey S, Obrietan K, Storm DR. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 1999; 23: 11-14.
173. Price MA, Cruzalegui FH, Treisman R. The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J 1996; 15: 6552-63.
174. Kurino M, Fukunaga K, Ushio Y, Miyamoto E. Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J Neurochem 1995; 65: 1282-89.
175. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-35.
176. Campbell JS, Seger R, Graves JD, Graves LM, Jensen AM, Krebs EG. The MAP kinase cascade. Recent Prog Horm Res 1995; 50: 131-59.
177. Davis RJ. Transcriptional regulation by MAP kinases. Mol Reprod Dev 1995; 42: 459-67.
178. Davis RJ. MAPKs: new JNK expands the group. Trends Biochem Sci 1994; 19: 470-73.
179. Ji RR, Rupp F. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J Neurosci 1997; 17: 1776-85.
180. Das S, Grunert M, Williams L, Vincent SR. NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 1997; 25: 227-33.
181. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996; 273: 959-63.
182. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999; 286: 1358-62.
183. Drickamer K, Taylor ME. Evolving views of protein glycosylation. Trends Biochem Sci 1998; 23: 321-24.
184. Van den Steen P, Rudd PM, Dwek RA, Opdenakker G. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 1998; 33: 151-208.
185. Opdenakker G, Rudd PM, Wormald M, Dwek RA, Van Damme J. Cells regulate the activities of cytokines by glycosylation. FASEB J 1995; 9: 453-57.
186. Opdenakker G, Rudd PM, Ponting CP, Dwek RA. Concepts and principles of glycobiology. FASEB J 1993; 7: 1330-37.
187. Lucas R, Magez S, De Leys R et al. Mapping the lectin-like activity of tumor necrosis factor. Science 1994; 263: 814-17.
188. Sherblom AP, Sathyamoorthy N, Decker JM, Muchmore AV. IL-2, a lectin with specificity for high mannose glycopeptides. J Immunol 1989; 143: 939-44.
189. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997; 81: 255-62.
190. Wagner R, Myers RR. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. NeuroReport 1996; 7: 2897-901.
191. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996; 73: 625-29.
192. 2+ channels. FEBS Lett 1995; 364: 129-33.
193. 2+ channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron 1996; 16: 431-40.
194. 2δ calcium channel subunit in dorsal root ganglia of rats with nerve injury-induced tactile allodynia. [Abstract]. Soc Neurosci Abst 1999; 25: 272.6.
195. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271: 5768-76.
196. Mellick LB, Mellick GA. Successful treatment of reflex sympathetic dystrophy with gabapentin [letter]. Am J Emerg Med 1995; 13: 96.
197. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996; 12: 56-58.
198. Mellick GA, Mellick LB. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil 1997; 78: 98-105.
199. Rosenberg JM, Harrell C, Ristic H, Werner RA, de Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain 1997; 13: 251-55.
200. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831-36.
201. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42.
202. Hwang JH, Yaksh TL. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 1997; 22: 249-56.
203. Abdi S, Lee DH, Chung JM. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998; 87: 1360-66.
204. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (neurontin and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997; 121: 1513-22.
205. Akopian AN, Abson NC, Wood JN. Molecular genetic approaches to nociceptor development and function. Trends Neurosci 1996; 19: 240-46.
206. Koller BH, Smithies O. Altering genes in animals by gene targeting. Annu Rev Immunol 1992; 10: 705-30.
207. Melton DW. Gene targeting in the mouse. Bioessays 1994; 16: 633-38.
208. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin F-T. Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 1999; 286: 2495-98.
209. Rubinstein M, Mogil JS, Japón M, Chan EC, Allen RG, Low MJ. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc Natl Acad Sci U S A 1996; 93: 3995-4000.
210. Jiang M, Gold MS, Boulay G et al. Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci U S A 1998; 95: 3269-74.
211. Simonin F, Valverde O, Smadja C et al. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 1998; 17: 886-97.
212. Davis BM, Lewin GR, Mendell LM, Jones ME, Albers KM. Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli. Neuroscience 1993; 56: 789-92.
213. Mansikka H, Shiotani M, Winchurch R, Raja SN. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiology 1999; 90: 1643-19.
214. Crosby G, Marota JJ, Huang PL. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 1995; 69: 1013-17.
215. Shi TJ, Zhang X, Berge OG, Erickson JC, Palmiter RD, Hökfelt T. Effect of peripheral axotomy on dorsal root ganglion neuron phenotype and autonomy behaviour in neuropeptide Y-deficient mice. Regul Pept 1998; 75-76: 161-73.
216. Malmberg AB, Brandon EP, Idzerda RL, Liu H, McKnight GS, Basbaum AI. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J Neurosci 1997; 17: 7462-70.
217. Malmberg AB, Chen C, Tonegawa S, Basbaum AI. Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 1997; 278: 279-83.
218. König M, Zimmer AM, Steiner H et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996; 383: 535-38.
219. Matthes HW, Maldonado R, Simonin F et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996; 383: 819-23.
220. Sora I, Takahashi N, Funada M et al. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A 1997; 94: 1544-19.
221. Zhu Y, King M, Schuller A, Unterwald E, Pasternak G, Pintar JE. Genetic disruption of the mouse delta opioid receptor gene [Abstract]. Soc Neurosci Abst 1997; 23: 584.
222. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell-type-specific gene targeting. Science 1994; 265: 103-106.
223. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993; 13: 2136-48.
224. Bozic CR, Lu B, Höpken UE, Gerard C, Gerard NP. Neurogenic amplification of immune complex inflammation. Science 1996; 273: 1722-25.
225. Mantyh PW, Rogers SD, Honore P et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997; 278: 275-79.
226. Devor M, Papir-Kricheli D, Nachmias E et al. Substance P-induced cutaneous plasma extravasation in rats is mediated by NK-1 tachykinin receptors. Neurosci Lett 1989; 103: 203-208.
227. Dougherty PM, Palecek J, Paleckova V, Sorkin LS, Willis WD. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci 1992; 12: 3025-41.
228. Dougherty PM, Palecek J, Zorn S, Willis WD. Combined application of excitatory amino acids and substance P produces long-lasting changes in responses of primate spinothalamic tract neurons. Brain Res Brain Res Rev 1993; 18: 227-46.
229. Dougherty PM, Palecek J, Paleckova V, Willis WD. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. J Neurophysiol 1994; 72: 1464-75.
230. Dougherty PM, Palecek J, Paleckova V, Willis WD. Infusion of substance P or neurokinin A by microdialysis alters responses of primate spinothalamic tract neurons to cutaneous stimuli and to iontophoretically released excitatory amino acids. Pain 1995; 61: 411-25.
231. Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257: 1276-79.
232. Traub RJ. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 1996; 67: 151-161.
233. Kühn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995; 269: 1427-29.
234. Sauer B, Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage Pl. Proc Natl Acad Sci U S A 1988; 85: 5166-70.
235. Orban PC, Chui D, Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 1992; 89: 6861-65.
236. Lakso M, Sauer B, Mosinger B et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A 1992; 89: 6232-36.
237. Nichols ML, Allen BJ, Rogers SD et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999; 286: 1558-61.
238. Lappi DA, Esch FS, Barbieri L, Stirpe F, Soria M. Characterization of a Saponaria officinalis seed ribosome-inactivating protein: immunoreactivity and sequence homologies. Biochem Biophys Res Commun 1985; 129: 934-42.
239. Lucas JJ, Mellström B, Colado MI, Naranjo JR. Molecular mechanisms of pain: serotoninlA receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons. Neuron 1993; 10: 599-611.
240. Lönnberg H, Vuorio E. Towards genomic drug therapy with antisense oligonucleotides. Ann Med 1996; 28: 511-22.
241. Crooke ST, Bennett CF. Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol 1996; 36: 107-29.
242. Crooke ST. Advances in understanding the pharmacological properties of antisense oligonucleotides. Adv Pharmacol 1997; 40: 1-49.
243. Hélène C, Toulmé JJ. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99-125.
244. Crooke ST. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J 1993; 7: 533-39.
245. Crooke ST. An overview of progress in antisense therapeutics. Antisense Nucleic Acid Drug Dev 1998; 8: 115-22.
246. Crooke ST. Antisense therapeutics. Biotechnol Genet Eng Rev 1998; 15: 121-57.
247. Lee CE, Kest B, Jenab S, Inturrisi CE. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice. Brain Res Mol Brain Res 1997; 48: 17-22.
248. Hua XY, Chen P, Polgar E et al. Spinal neurokinin NK1 receptor down-regulation and antinociception: effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy. J Neurochem 1998; 70: 688-98.
249. Khasar SG, Gold MS, Levine JD. A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett 1998; 256: 17-20.
250. Levesque L, Dean NM, Sasmor H, Crooke ST. Antisense oligonucleotides targeting human protein kinase C-alpha inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells. Mol Pharmacol 1997; 51: 209-16.
251. Wahlestedt C, Golanov E, Yamamoto S et al. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 1993; 363: 260-63.
252. Stein CA, Narayanan R. Antisense oligodeoxynucleotides. Curr Opin Oncol 1994; 6: 587-94.
253. Stein CA, Krieg AM. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides [Editorial]. Antisense Res Dev 1994; 4: 67-69.
254. Matthes E, Lehmann C. Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides. Nucleic Acids Res 1999; 27: 1152-58.
255. Scanlon KJ, Ohta Y, Ishida H et al. Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 1995; 9: 1288-96.
256. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991; 254: 1497-500.
257. Wittung P, Nielsen PE, Buchardt O, Egholm M, Nordén B. DNA-like double helix formed by peptide nucleic acid. Nature 1994; 368: 561-63.
258. Egholm M, Buchardt O, Christensen L et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 1993; 365: 566-68.
259. Demidov VV, Potaman VN, Frank-Kamenetskii MD et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol 1994; 48: 1310-13.
260. Good L, Nielsen PE. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat Biotechnol 1998; 16: 355-58.
261. Good L, Nielsen PE. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc Natl Acad Sci U S A 1998; 95: 2073-76.
262. Hanvey JC, Peffer NJ, Bisi JE et al. Antisense and antigene properties of peptide nucleic acids. Science 1992; 258: 1481-85.
263. Bonham MA, Brown S, Boyd AL et al. An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res 1995; 23: 1197-203.
264. Knudsen H, Nielsen PE. Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res 1996; 24: 494-500.
265. Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR. Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotechnol 1996; 14: 615-19.
266. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 1997; 15: 212-15.
267. Nielsen PE, Egholm M, Buchardt O. Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand. Gene 1994; 149: 139-45.
268. Wittung P, Kajanus J, Edwards K et al. Phospholipid membrane permeability of peptide nucleic acid [corrected and republished with original paging, article originally printed in FEBS Lett 1995; 365: 27-29]. FEBS Lett 1995; 375: 27-29.
269. Nielsen PE. DNA analogues with nonphosphodiester backbones. Annu Rev Biophys Biomol Struct 1995; 24: 167-83.
270. Good L, Nielsen PE. Progress in developing PNA as a gene-targeted drug. Antisense Nucleic Acid Drug Dev 1997; 7: 431-37.
271. Nielsen PE. Peptide nucleic acid (PNA) from DNA recognition to antisense and DNA structure. Biophys Chem 1997; 68: 103-108.
272. Pooga M, Soomets U, Hällbrink M et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 1998; 16: 857-61.
273. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994; 6: 1903-12.
274. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1-164.
275. Murphy RA, Acheson A, Hodges R et al. Immunological relationships of NGF, BDNF, and NT-3: recognition and functional inhibition by antibodies to NGF. J Neurosci 1993; 13: 2853-62.
276. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362-64.
277. + channel accumulation on axolemma of afferent endings in nerve end neuromas in Apteronotus. Neurosci Lett 1989; 102: 149-54.
278. England JD, Gamboni F, Ferguson MA, Levinson SR. Sodium channels accumulate at the tips of injured axons. Muscle Nerve 1994; 17: 593-98.
279. England JD, Happel LT, Kline DG et al. Sodium channel accumulation in humans with painful neuromas. Neurology 1996; 47: 272-76.
280. + channels. J Neurophysiol 1994; 72: 349-59.
281. Cummins TR, Waxman SG. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 1997; 17: 3503-14.
282. Zhang JM, Donnelly DF, Song XJ, Lamotte RH. Axotomy increases the excitability of dorsal root ganglion cells with unmyelinated axons. J Neurophysiol 1997; 78: 279094.
283. + current in nociceptors. Proc Natl Acad Sci U S A 1996; 93: 1108-12.
284. Yoon YW, Sung B, Chung JM. Nitric oxide mediates behavioral signs of neuropathic pain in an experimental rat model. NeuroReport 1998; 9: 367-72.
285. Brown JP, Gee NS. Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity. J Biol Chem 1998; 273: 25458-65.
286. 2+ channel subunit from porcine brain: development of a radioligand binding assay for alpha 2 delta subunits using [3H]leucine. Anal Biochem 1998; 255: 236-43.
287. Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy [Letter]. J Pain Symptom Manage 1995; 10: 265-66.